Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 15, 2021 - Issue 1
Submit an article Journal homepage
1,167
Views
2
CrossRef citations to date
0
Altmetric
Editorial

C-reactive protein point of care testing: the answer to antibiotic prescribing in ambulatory patients with exacerbations of chronic obstructive pulmonary disease?

Carl Llora Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark;b University Institute in Primary Care Research Jordi Gol, via Roma Health Centre, Barcelona, SpainCorrespondence[email protected]
View further author information
&
Marc Miravitllesc Pneumology Department, Hospital Universitari Vall d’Hebron/Vall d’Hebron Research Institute (VHIR). CIBER de Enfermedades Respiratorias (CIBERS), Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-9850-9520View further author information
ORCID Icon
Pages 1-3 | Received 10 Apr 2020, Accepted 28 May 2020, Published online: 04 Jun 2020

References

  • Al-Jaghbeer MJ, Justo JA, Owens W, et al. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018;46:487–494.
  • World Health Organization. Global Action Plan on antimicrobial resistance. 2015. [cited 2020 Jun 1]. Available from: https://www.who.int/antimicrobial-resistance/global-action-plan/en/
  • Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173:1114–1121.
  • Gonzales R, Camargo CA Jr, MacKenzie T, et al. Antibiotic treatment of acute respiratory infections in acute care settings. Acad Emerg Med. 2006;13:288–294.
  • Vollenweider DJ, Jarrett H, Steurer-Stey CA, et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;12:CD010257.
  • Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196–204.
  • Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: an European Respiratory Society/American Thoracic Society (ERS/ATS) guideline. Eur Respir J. 2017;49:1600791.
  • Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174:867–874.
  • Fermont JM, Masconi KL, Jensen MT, et al. Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis. Thorax. 2019;74:439–446.
  • Sneh A, Pawan T, Randeep G, et al. Acute phase proteins as predictors of survival in patients with acute exacerbation of chronic obstructive pulmonary disease requiring mechanical ventilation. COPD. 2020;17:22–28.
  • Miravitlles M, Monteagudo M, Solntseva I, et al. Blood eosinophil counts and their variability and risk of exacerbations in COPD: A population-based study. Arch Bronconeumol. 2020 Feb 12:pii: S0300-2896(19)30623–4. [ Epub ahead of print]. DOI:10.1016/j.arbres.2019.12.015
  • Mayhew D, Devos N, Lambert C, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018;73:422–430.
  • Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18:95–107.
  • Soler N, Esperatti M, Ewig S, et al. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD. Eur Respir J. 2012;40:1344–1353.
  • European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2018: European Centre for Disease Prevention and Control. 2019. [cited 2020 Jun 1]. Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-europe
  • Verbakel JY, Lee JJ, Goyder C, et al. Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis. BMJ Open. 2019;9:1–11.
  • Butler CC, Gillespie D, White P, et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. N Engl J Med. 2019;381:111–120.
  • Alcázar Navarrete B, Ancochea Bermúdez J, García-Río F, et al. Patients with chronic obstructive pulmonary disease exacerbations: recommendations for diagnosis, treatment and care. Arch Bronconeumol. 2019;55:478–487.
  • Llor C, Moragas A, Hernández S, et al. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:716–723.
  • Miravitlles M, Moragas A, Hernández S, et al. Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment? Chest. 2013;144:1571–1577.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.